株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

静脈瘤性潰瘍:世界における治験レビュー

Varicose Ulcers Global Clinical Trials Review, H2, 2016

発行 GlobalData 商品コード 296025
出版日 ページ情報 英文 35 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.83円で換算しております。
Back to Top
静脈瘤性潰瘍:世界における治験レビュー Varicose Ulcers Global Clinical Trials Review, H2, 2016
出版日: 2016年12月14日 ページ情報: 英文 35 Pages
概要

当レポートでは、静脈瘤性潰瘍の治療薬に関する治験について調査分析し、治験数および被験者数、段階別・相別の状況、有望企業、開発中の治療薬の情報、治験プロファイルなどを提供して、概略以下の構成でお届けいたします。

目次

イントロダクション

地域別の治験

  • 国別の治験動向
    • アジア太平洋地域の主要国
    • 欧州の主要国
    • 北米の主要国

G7諸国における治験:皮膚科の治験に対する静脈瘤性潰瘍の割合

G7諸国における治験:相別

G7諸国における治験:段階別

E7諸国における治験:皮膚科の治験に対する静脈瘤性潰瘍の割合

E7諸国における治験:相別

相別の治験

  • 進行中の治験 :相別

段階別の治験

評価項目別の治験

未完了の治験

一定期間に採用された被験者

スポンサータイプ別の治験

有望なスポンサー

  • 静脈瘤性潰瘍治療薬の治験に参加している主要企業

有望な治療薬

治験プロファイル

  • 主要企業の治験概要
    • Shire Plc
    • SERICARE
    • Renovo Group Plc
    • CardioVascular BioTherapeutics, Inc.
  • 主要大学・研究機関・病院の治験概要
    • Department of Health, South Africa
    • NHS Trusts Clinical Trials
    • Veterans Affairs Medical Center
    • AFRETH
    • Ruhr University Bochum
    • University of Hull
    • The Ohio State University
    • Queen's University
    • University of Pennsylvania
    • U.S. Department of Veterans Affairs

主な臨床プロファイル

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC4004CTIDB

GlobalData's clinical trial report, "Varicose Ulcers Global Clinical Trials Review, H2, 2016" provides an overview of Varicose Ulcers clinical trials scenario. This report provides top line data relating to the clinical trials on Varicose Ulcers. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 3
  • Report Guidance 4
  • Clinical Trials by Region 5
  • Clinical Trials and Average Enrollment by Country 6
  • Top Countries Contributing to Clinical Trials in Asia-Pacific 8
  • Top Five Countries Contributing to Clinical Trials in Europe 9
  • Top Countries Contributing to Clinical Trials in North America 10
  • Top Countries Contributing to Clinical Trials in Central and South America 11
  • Clinical Trials by G7 Countries: Proportion of Varicose Ulcers to Dermatology Clinical Trials 12
  • Clinical Trials by Phase in G7 Countries 13
  • Clinical Trials in G7 Countries by Trial Status 14
  • Clinical Trials by E7 Countries: Proportion of Varicose Ulcers to Dermatology Clinical Trials 15
  • Clinical Trials by Phase in E7 Countries 16
  • Clinical Trials in E7 Countries by Trial Status 17
  • Clinical Trials by Phase 18
  • Clinical Trials by Trial Status 19
  • Clinical Trials by End Point Status 20
  • Clinical Trials by Sponsor Type 21
  • Prominent Sponsors 22
  • Top Companies Participating in Varicose Ulcers Therapeutics Clinical Trials 23
  • Prominent Drugs 25
  • Clinical Trial Profile Snapshots 26

Appendix 32

  • Abbreviations 32
  • Definitions 32
  • Research Methodology 33
  • Secondary Research 33
  • About GlobalData 34
  • Contact Us 34
  • Disclaimer 34
  • Source 35

List of Tables

List of Tables

  • Varicose Ulcers Therapeutics, Global, Clinical Trials by Region, 2016* 5
  • Varicose Ulcers Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
  • Varicose Ulcers Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
  • Varicose Ulcers Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 8
  • Varicose Ulcers Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 9
  • Varicose Ulcers Therapeutics Clinical Trials, North America, Top Countries, 2016* 10
  • Varicose Ulcers Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 11
  • Proportion of Varicose Ulcers to Dermatology Clinical Trials, G7 Countries (%), 2016* 12
  • Varicose Ulcers Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 13
  • Varicose Ulcers Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 14
  • Proportion of Varicose Ulcers to Dermatology Clinical Trials, E7 Countries (%), 2016* 15
  • Varicose Ulcers Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 16
  • Varicose Ulcers Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 17
  • Varicose Ulcers Therapeutics, Global, Clinical Trials by Phase, 2016* 18
  • Varicose Ulcers Therapeutics, Global, Clinical Trials by Trial Status, 2016* 19
  • Varicose Ulcers Therapeutics Clinical Trials, Global, by End Point Status, 2016* 20
  • Varicose Ulcers Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 21
  • Varicose Ulcers Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 22
  • Varicose Ulcers Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 24
  • Varicose Ulcers Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 25

List of Figures

List of Figures

  • Varicose Ulcers Therapeutics, Global, Clinical Trials by Region (%), 2016* 5
  • Varicose Ulcers Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
  • Varicose Ulcers Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
  • Varicose Ulcers Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 9
  • Proportion of Varicose Ulcers to Dermatology Clinical Trials, G7 Countries (%), 2016* 12
  • Varicose Ulcers Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 13
  • Varicose Ulcers Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 14
  • Proportion of Varicose Ulcers to Dermatology Clinical Trials, E7 Countries (%), 2016* 15
  • Varicose Ulcers Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 16
  • Varicose Ulcers Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 17
  • Varicose Ulcers Therapeutics, Global, Clinical Trials by Phase (%), 2016* 18
  • Varicose Ulcers Therapeutics, Global, Clinical Trials by Trial Status, 2016* 19
  • Varicose Ulcers Therapeutics Clinical Trials, Global, by End Point Status, 2016* 20
  • Varicose Ulcers Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 21
  • Varicose Ulcers Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 22
  • Varicose Ulcers Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 23
  • Varicose Ulcers Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 25
  • GlobalData Methodology 33
Back to Top